iRhythm Zio

A doctor and a patient looking at information on a tablet.
iRhythm Technologies receives another FDA 510(k) for AFib monitoring system
By Emily Olsen | 01:08 pm | July 22, 2022
The latest clearance is for an algorithm that characterizes how much atrial fibrillation a patient is experiencing over time.
iRhythm lauds growing revenue, sales force expansion during Q1 2018 earnings call
By Dave Muoio | 05:21 pm | May 08, 2018
iRhythm touts new, timely device on Q2 earnings call
By Jonah Comstock | 04:45 pm | August 08, 2017
With new FDA clearances, ZIO is poised to finally add realtime, connected monitoring
By Jonah Comstock | 02:23 pm | June 08, 2017
iRhythm goes public with $107M IPO
By Jonah Comstock | 03:09 pm | October 20, 2016